TLX EBITDA

TLX Annual EBITDA

$15.25 M
+$75.55 M+125.28%

01 December 2023

1-Year Change

+125.28%
TLX annual earnings before interest, taxes, depreciation & amortization is up +125.28% year-on-year

3-Year Change

+152.68%
TLX annual earnings before interest, taxes, depreciation & amortization is up +152.68% over the past 3 years

All-time High

$15.25 M
TLX annual earnings before interest, taxes, depreciation & amortization is currently at an all-time high

Sector Rank

82.24%
TLX annual earnings before interest, taxes, depreciation & amortization is higher than 82.24% of companies in Healthcare sector

Annual EBITDA Formula

Net Income + Interest + Taxes + Depreciation + Amortization
Annual Revenue$329.72 M
TLX annual revenue is $329.72 million
Annual Gross Profit$204.81 M
TLX annual gross profit is $204.81 million
Annual Net Income$3.46 M
TLX annual net profit is $3.46 million

TLX EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TLX EBITDA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+125.3%--
3 y3 years+152.7%--
5 y5 years+230.2%--

TLX EBITDA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+125.3%
5 y5-yearat high+125.3%
alltimeall timeat high+125.3%

Telix Pharmaceuticals Limited EBITDA History

DateAnnualQuarterlyTTM
Dec 2023
$15.25 M(-125.3%)
-
-
Dec 2022
-$60.31 M(+14.6%)
-
-
Dec 2021
-$52.62 M(+81.8%)
-
-
DateAnnualQuarterlyTTM
Dec 2020
-$28.94 M(+70.1%)
-
-
Dec 2019
-$17.02 M(+45.3%)
-
-
Dec 2018
-$11.71 M(+140.1%)
-
-
Dec 2017
-$4.88 M
-
-

FAQ

  • What is Telix Pharmaceuticals Limited annual earnings before interest, taxes, depreciation & amortization?
  • What is the all time high annual EBITDA for Telix Pharmaceuticals Limited?
  • What is Telix Pharmaceuticals Limited annual EBITDA year-on-year change?

What is Telix Pharmaceuticals Limited annual earnings before interest, taxes, depreciation & amortization?

The current annual EBITDA of TLX is $15.25 M

What is the all time high annual EBITDA for Telix Pharmaceuticals Limited?

Telix Pharmaceuticals Limited all-time high annual earnings before interest, taxes, depreciation & amortization is $15.25 M

What is Telix Pharmaceuticals Limited annual EBITDA year-on-year change?

Over the past year, TLX annual earnings before interest, taxes, depreciation & amortization has changed by +$75.55 M (+125.28%)